A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
Clinical trial NCT05236517 · COMPLETED
Trial details
- NCT number
- NCT05236517
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2022-09-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.